Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine PK/PD in Pediatric ICU Patients (12-24 months)
NCT01378988Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in sedation, pain, sponsored by Pfizer. Started Jun 2011; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
sedationpain
Beyond the preview
Go deeper on NCT01378988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01378988.